1. Home
  2. TCRX vs EQS Comparison

TCRX vs EQS Comparison

Compare TCRX & EQS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TScan Therapeutics Inc.

TCRX

TScan Therapeutics Inc.

SELL

Current Price

$0.14

Market Cap

11.8M

Sector

Health Care

ML Signal

SELL

Logo Equus Total Return Inc.

EQS

Equus Total Return Inc.

SELL

Current Price

$0.56

Market Cap

12.3M

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
TCRX
EQS
Founded
2018
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance Companies
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
11.8M
12.3M
IPO Year
2021
1995

Fundamental Metrics

Financial Performance
Metric
TCRX
EQS
Price
$0.14
$0.56
Analyst Decision
Hold
Analyst Count
5
0
Target Price
★ $1.00
N/A
AVG Volume (30 Days)
★ 420.2K
7.6K
Earning Date
11-12-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
★ 12.28
N/A
EPS
N/A
★ N/A
Revenue
★ $10,325,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 266.65
N/A
52 Week Low
$0.14
$0.53
52 Week High
$1.47
$2.05

Technical Indicators

Market Signals
Indicator
TCRX
EQS
Relative Strength Index (RSI) 31.39 43.24
Support Level N/A N/A
Resistance Level $0.21 $1.05
Average True Range (ATR) 0.02 0.06
MACD 0.00 0.01
Stochastic Oscillator 8.07 34.99

Price Performance

Historical Comparison
TCRX
EQS

About TCRX TScan Therapeutics Inc.

TScan Therapeutics Inc is a fully integrated clinical-stage biotechnology company focused on developing a robust pipeline of T cell receptor (TCR)-engineered T cell, or TCR-T, therapies for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.

About EQS Equus Total Return Inc.

Equus Total Return Inc is a United States-based closed-end management investment company. The company invests mainly in companies pursuing growth either through acquisition or organically, leveraged buyouts, management buyouts, and recapitalizations of existing businesses or special situations, and achieves capital appreciation by making investments in equity and equity-oriented securities issued by privately-owned companies or smaller public companies in transactions.

Share on Social Networks: